265 related articles for article (PubMed ID: 17397297)
41. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
42. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
[TBL] [Abstract][Full Text] [Related]
43. [Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides].
Liu J; Zheng YH; Zhou YF; Zhang JZ; Wang BX
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):100-4. PubMed ID: 19489271
[TBL] [Abstract][Full Text] [Related]
44. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
45. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
46. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
Rüetschi U; Zetterberg H; Podust VN; Gottfries J; Li S; Hviid Simonsen A; McGuire J; Karlsson M; Rymo L; Davies H; Minthon L; Blennow K
Exp Neurol; 2005 Dec; 196(2):273-81. PubMed ID: 16154129
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
48. Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.
Miguet L; Bogumil R; Decloquement P; Herbrecht R; Potier N; Mauvieux L; Van Dorsselaer A
J Proteome Res; 2006 Sep; 5(9):2258-69. PubMed ID: 16944938
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
50. Novel application of ProteinChip technology exploring acute rejection markers of rat small bowel transplantation.
Yamayoshi Y; Watanabe T; Tanabe M; Hoshino K; Matsumoto K; Morikawa Y; Shimadzu M; Kitajima M; Tanigawara Y
Transplantation; 2006 Aug; 82(3):320-6. PubMed ID: 16906028
[TBL] [Abstract][Full Text] [Related]
51. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.
Das S; Maeso PA; Becker AM; Prosser JD; Adam BL; Kountakis SE
Laryngoscope; 2008 Dec; 118(12):2231-4. PubMed ID: 18978510
[TBL] [Abstract][Full Text] [Related]
52. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
53. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
Carlson SM; Najmi A; Whitin JC; Cohen HJ
Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
[TBL] [Abstract][Full Text] [Related]
54. Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights?
Wölfler MM; Schwamborn K; Otten D; Hornung D; Liu H; Rath W
Fertil Steril; 2009 Jun; 91(6):2331-7. PubMed ID: 18555242
[TBL] [Abstract][Full Text] [Related]
55. Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.
Liu W; Li X; Ding F; Li Y
Scand J Rheumatol; 2008; 37(2):94-102. PubMed ID: 18415765
[TBL] [Abstract][Full Text] [Related]
56. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
Sandoval JA; Dobrolecki LE; Huang J; Grosfeld JL; Hickey RJ; Malkas LH
J Pediatr Surg; 2006 Apr; 41(4):639-46; discussion 639-46. PubMed ID: 16567169
[TBL] [Abstract][Full Text] [Related]
57. A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Fenollar F; Goncalves A; Esterni B; Azza S; Habib G; Borg JP; Raoult D
J Infect Dis; 2006 Nov; 194(10):1356-66. PubMed ID: 17054064
[TBL] [Abstract][Full Text] [Related]
58. [Preliminary study of serum proteome biomarkers of hypopharyngeal squamous cell carcinoma].
Cheng L; Zhou L; Tao L; Xiang CQ; Jia XD; Lu Y; Liao P
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1484-8. PubMed ID: 16842702
[TBL] [Abstract][Full Text] [Related]
59. SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease.
Gomes-Alves P; Imrie M; Gray RD; Nogueira P; Ciordia S; Pacheco P; Azevedo P; Lopes C; de Almeida AB; Guardiano M; Porteous DJ; Albar JP; Boyd AC; Penque D
Clin Biochem; 2010 Jan; 43(1-2):168-77. PubMed ID: 19850022
[TBL] [Abstract][Full Text] [Related]
60. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis.
Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L
Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
